株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

アテローム除去デバイスおよび血栓除去デバイスの世界市場:2015年〜2019年

Global Atherectomy and Thrombectomy Devices Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 269615
出版日 ページ情報 英文 81 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
アテローム除去デバイスおよび血栓除去デバイスの世界市場:2015年〜2019年 Global Atherectomy and Thrombectomy Devices Market 2015-2019
出版日: 2015年08月19日 ページ情報: 英文 81 Pages
概要

世界のアテローム除去デバイスおよび血栓除去デバイス市場は、2014年〜2019年のCAGRで、6.25%の成長が見込まれています。

当レポートでは、世界のアテローム除去デバイスおよび血栓除去デバイス市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 世界のアテローム除去デバイスおよび血栓除去デバイス市場

  • 市場概要
    • 市場規模と予測

第7章 世界のアテローム除去デバイスおよび血栓除去デバイス市場区分:製品タイプ別

  • アテローム除去デバイス
  • 血栓除去デバイス
  • ファイブフォース分析

第8章 世界のアテローム除去デバイス市場

  • 市場概要
    • 市場規模と予測
  • 市場区分:処置の種類別

第9章 世界の血栓除去デバイス市場

  • 市場概要
    • 市場規模と予測
  • 市場区分:製品タイプ別
  • 市場区分:処置の種類別

第10章 アテローム除去デバイスおよび血栓除去デバイスの償還シナリオ

  • 南北アメリカの償還シナリオ
  • 欧州・中東・アフリカの償還シナリオ
  • アジア太平洋地域の償還シナリオ

第11章 地理区分

  • 南北アメリカのアテローム除去デバイスおよび血栓除去デバイス市場
    • 市場規模と予測
  • 欧州・中東・アフリカのアテローム除去デバイスおよび血栓除去デバイス市場
    • 市場規模と予測
  • アジア太平洋地域のアテローム除去デバイスおよび血栓除去デバイス市場
    • 市場規模と予測

第12章 購入基準

第13章 市場成長促進要因

第14章 成長促進要因とその影響

第15章 市場の課題

第16章 成長促進要因と課題の影響

第17章 市場動向

第18章 動向とその影響

第19章 ベンダー情勢

  • 競合シナリオ
  • ベンダー分析

第20章 主要ベンダーの分析

  • Boston Scientific Group
  • Cardiovascular Systems
  • Medtronic
  • Spectranetics

第21章 関連レポート

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR6543

About Atherectomy and Thrombectomy Devices

Atherectomy devices are used to remove atherosclerotic plaques to clear blocked blood vessels. Atherosclerotic plaques are deposits of fats, calcium, or other substances inside the blood vessels. It is an endovascular procedure for the treatment of PAD and CAD. PVD refers to damaged or blocked peripheral blood vessels that supply blood to the arms, legs, and organs other than brain and heart. PAD, which is PVD of the arteries, is known to increase the risk of stroke and heart attack by up to six times. CAD is a condition of narrowing of arteries that supply blood to heart muscles. Stents, balloon catheters, atherectomy devices are used in endovascular procedures to treat PVD. Thrombectomy devices are used to surgically remove thrombi (clot) from the blood vessels during the treatment of DVT. DVT is the blood clot formed in deep veins in the body, mainly in legs. The risk of developing these vascular diseases increases with age. Diabetes, high blood pressure, obesity, and smoking are other risk factors for these diseases.

Technavio's analysts forecast the global atherectomy and thrombectomy market to grow at a CAGR of 6.25% over the period 2014-2019.

Covered in this Report

The report includes the present scenario and the growth prospects of the global atherectomy and thrombectomy devices market for the period 2015-2019. The market can be segmented into two divisions: atherectomy devices and thrombectomy devices.

Technavio's report, Global Atherectomy and Thrombectomy Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global atherectomy and thrombectomy devices market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Boston Scientific Group
  • Cardiovascular Systems
  • Medtronic
  • Spectranetics

Other Prominent Vendors

  • Argon Medical Devices
  • C.R. Bard
  • Cod Man Neuro (DePuy Orthopaedics)
  • Cook Medical
  • Edwards Lifesciences
  • IDEV Technologies (subsidiary of Abbott Vascular)
  • Lake Region Medical
  • NexGen Medical Systems
  • Reverse Medical
  • St. Jude Medical
  • Teleflex Medical
  • Volcano (acquired by Philips)

Key Market Driver

  • Growing Prevalence of PAD and DVT
  • For a full, detailed list, view our report

Key Market Challenge

  • Product Recalls
  • For a full, detailed list, view our report

Key Market Trend

  • Growing Number of Acquisitions
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings
    • 03.2.1. Atherectomy Products
    • 03.2.2. Thrombectomy Products

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Global Atherectomy and Thrombectomy Devices Market

  • 06.1. Market Overview
    • 06.1.1. Market Size and Forecast

07. Global Atherectomy and Thrombectomy Market Segmentation by Product Type

  • 07.1. Atherectomy Devices
  • 07.2. Thrombectomy Devices
  • 07.3. Five Forces Analysis

08. Global Atherectomy Devices Market

  • 08.1. Market Overview
    • 08.1.1. Market Size and Forecast
  • 08.2. Market Segmentation by Procedure Type

09. Global Thrombectomy Devices Market

  • 09.1. Market Overview
    • 09.1.1. Market Size and Forecast
  • 09.2. Market Segmentation by Product Type
  • 09.3. Market Segmentation by Procedure Type

10. Reimbursement Scenario of Atherectomy and Thrombectomy Devices

  • 10.1. Reimbursement Scenario in Americas
  • 10.2. Reimbursement Scenario in EMEA
  • 10.3. Reimbursement Scenario in APAC

11. Geographical Segmentation

  • 11.1. Atherectomy and Thrombectomy Devices Market in Americas
    • 11.1.1. Market Size and Forecast
  • 11.2. Atherectomy and Thrombectomy Devices Market in EMEA
    • 11.2.1. Market Size and Forecast
  • 11.3. Atherectomy and Thrombectomy Devices Market in APAC
    • 11.3.1. Market Size and Forecast

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

  • 19.1. Competitive Scenario
    • 19.1.1. Key News
    • 19.1.2. Mergers and Acquisitions
  • 19.2. Vendor Analysis 2015
    • 19.2.1. Boston Scientific Group
    • 19.2.2. Cardiovascular Systems
    • 19.2.3. Medtronic
    • 19.2.4. Spectranetics
    • 19.2.5. Other Prominent Vendors

20. Key Vendor Analysis

  • 20.1. Boston Scientific Group
    • 20.1.1. Key Facts
    • 20.1.2. Business Overview
    • 20.1.3. Business Segmentation
    • 20.1.4. Business Strategy
    • 20.1.5. Business Segmentation by Revenue
    • 20.1.6. Business Segmentation by Revenue 2012 and 2013
    • 20.1.7. Geographical Segmentation by Revenue
    • 20.1.8. Key Developments
    • 20.1.9. SWOT Analysis
  • 20.2. Cardiovascular Systems
    • 20.2.1. Key Facts
    • 20.2.2. Business Overview
    • 20.2.3. Product Segmentation Based on Therapy Areas
    • 20.2.4. Business Strategy
    • 20.2.5. Recent Developments
    • 20.2.6. SWOT Analysis
  • 20.3. Medtronic
    • 20.3.1. Key Facts
    • 20.3.2. Business Overview
    • 20.3.3. Business Segmentation by Revenue 2013
    • 20.3.4. Business Segmentation by Revenue 2012 and 2013
    • 20.3.5. Geographical Segmentation by Revenue 2013
    • 20.3.6. Business Strategy
    • 20.3.7. Recent Developments
    • 20.3.8. SWOT Analysis
  • 20.4. Spectranetics
    • 20.4.1. Key Facts
    • 20.4.2. Business Overview
    • 20.4.3. Business Segmentation 2014
    • 20.4.4. Business Segmentation by Revenue 2013 and 2014
    • 20.4.5. Geographical Segmentation by Revenue 2014
    • 20.4.6. Business Strategy
    • 20.4.7. Recent Developments
    • 20.4.8. SWOT Analysis

21. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Atherectomy and Thrombectomy Devices Market 2014-2019 ($ million)
  • Exhibit 3: Global Atherectomy and Thrombectomy Devices Market: Segmentation by Product Type
  • Exhibit 4: Global Atherectomy and Thrombectomy Devices Market 2014
  • Exhibit 5: Global Atherectomy Devices Market 2014-2019 ($ million)
  • Exhibit 6: Global Atherectomy Devices Market: Segmentation by Procedure Type
  • Exhibit 7: Global Thrombectomy Devices Market 2014-2019 ($ million)
  • Exhibit 8: Global Thrombectomy Devices Market: Segmentation by Product Type
  • Exhibit 9: Segmentation of Global Thrombectomy Devices Market by Procedure Type
  • Exhibit 10: Global Atherectomy and Thrombectomy Devices Market 2014-2019
  • Exhibit 11: Global Atherectomy and Thrombectomy Devices Market 2014-2019($ million)
  • Exhibit 12: Reimbursement for Atherectomy (Medicare)
  • Exhibit 13: Reimbursement for Thrombectomy (Medicare)
  • Exhibit 14: Geographical Segmentation of Global Atherectomy and Thrombectomy Devices Market 2014
  • Exhibit 15: Atherectomy and Thrombectomy Devices Market in Americas 2014-2019 ($ million)
  • Exhibit 16: Atherectomy and Thrombectomy Devices Market in EMEA 2014-2019 ($ million)
  • Exhibit 17: Atherectomy and Thrombectomy Devices Market in APAC 2014-2019 ($ million)
  • Exhibit 18: Geographical Segmentation of Global Atherectomy and Thrombectomy Devices Market 2014-2019
  • Exhibit 19: Geographical Segmentation of Global Atherectomy and Thrombectomy Devices Market 2014-2019 ($ million)
  • Exhibit 20: Key Takeaways: Boston Scientific Group
  • Exhibit 21: Key Takeaways: Cardiovascular Systems
  • Exhibit 22: Key Takeaways: Medtronic
  • Exhibit 23: Key Takeaways: Spectranetics
  • Exhibit 24: Boston Scientific: Business Segmentation 2013
  • Exhibit 25: Boston Scientific: Business Segmentation by Revenue 2013
  • Exhibit 26: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 27: Boston Scientific: Geographical Segmentation by Revenue 2012 and 2013 2013
  • Exhibit 28: Cardiovascular Systems: Product Segmentation Based on Therapy Areas
  • Exhibit 29: Medtronic: Business Segmentation by Revenue 2013
  • Exhibit 30: Medtronic: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 31: Medtronic: Geographical Segmentation by Revenue 2013
  • Exhibit 32: Spectranetics: Business Segmentation 2014
  • Exhibit 33: Spectranetics: Business Segmentation by Revenue 2013 and 2014 ($ million)
  • Exhibit 34: Spectranetics: Geographical Segmentation by Revenue 2014
Back to Top